These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 21666213

  • 1. Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission.
    Rota JS, Hickman CJ, Sowers SB, Rota PA, Mercader S, Bellini WJ.
    J Infect Dis; 2011 Jul; 204 Suppl 1():S559-63. PubMed ID: 21666213
    [Abstract] [Full Text] [Related]

  • 2. Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G.
    Sanz-Moreno JC, Limia-Sánchez A, García-Comas L, Mosquera-Gutiérrez MM, Echevarria-Mayo JE, Castellanos-Nadal A, de Ory-Manchón F.
    Vaccine; 2005 Sep 30; 23(41):4921-5. PubMed ID: 15996797
    [Abstract] [Full Text] [Related]

  • 3. Outbreak of measles among persons with prior evidence of immunity, New York City, 2011.
    Rosen JB, Rota JS, Hickman CJ, Sowers SB, Mercader S, Rota PA, Bellini WJ, Huang AJ, Doll MK, Zucker JR, Zimmerman CM.
    Clin Infect Dis; 2014 May 30; 58(9):1205-10. PubMed ID: 24585562
    [Abstract] [Full Text] [Related]

  • 4. Hospital-associated measles outbreak - Pennsylvania, March-April 2009.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2012 Jan 20; 61(2):30-2. PubMed ID: 22258416
    [Abstract] [Full Text] [Related]

  • 5. Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006.
    Rota JS, Turner JC, Yost-Daljev MK, Freeman M, Toney DM, Meisel E, Williams N, Sowers SB, Lowe L, Rota PA, Nicolai LA, Peake L, Bellini WJ.
    J Med Virol; 2009 Oct 20; 81(10):1819-25. PubMed ID: 19697404
    [Abstract] [Full Text] [Related]

  • 6. Air travel as a risk factor for introduction of measles in a highly vaccinated population.
    van Binnendijk RS, Hahné S, Timen A, van Kempen G, Kohl RH, Boot HJ, Wolthers KC, Wetsteijn JC, de Vries A, Westert K, Brown KE, de Swart RL.
    Vaccine; 2008 Oct 29; 26(46):5775-7. PubMed ID: 18786588
    [Abstract] [Full Text] [Related]

  • 7. Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals.
    Hickman CJ, Hyde TB, Sowers SB, Mercader S, McGrew M, Williams NJ, Beeler JA, Audet S, Kiehl B, Nandy R, Tamin A, Bellini WJ.
    J Infect Dis; 2011 Jul 29; 204 Suppl 1():S549-58. PubMed ID: 21666212
    [Abstract] [Full Text] [Related]

  • 8. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
    Hamkar R, Mahmoodi M, Nategh R, Jelyani KN, Eslami MB, Mohktari-Azad T.
    East Mediterr Health J; 2006 Nov 29; 12(6):775-82. PubMed ID: 17333822
    [Abstract] [Full Text] [Related]

  • 9. The largest outbreak of measles in the United States during 1999: imported measles and pockets of susceptibility.
    Rooney JA, Milton DJ, Hackler RL, Harris JH, Reynolds D, Tanner M, Taylor E.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S78-80. PubMed ID: 15106093
    [Abstract] [Full Text] [Related]

  • 10. Measles Outbreak Among Previously Immunized Healthcare Workers, the Netherlands, 2014.
    Hahné SJ, Nic Lochlainn LM, van Burgel ND, Kerkhof J, Sane J, Yap KB, van Binnendijk RS.
    J Infect Dis; 2016 Dec 15; 214(12):1980-1986. PubMed ID: 27923955
    [Abstract] [Full Text] [Related]

  • 11. Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life.
    Nair N, Gans H, Lew-Yasukawa L, Long-Wagar AC, Arvin A, Griffin DE.
    J Infect Dis; 2007 Nov 01; 196(9):1339-45. PubMed ID: 17922398
    [Abstract] [Full Text] [Related]

  • 12. [Measles at the point of being eliminated].
    De Ory F, Peña-Rey I.
    Enferm Infecc Microbiol Clin; 2010 Feb 01; 28(2):73-4. PubMed ID: 20096973
    [No Abstract] [Full Text] [Related]

  • 13. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy.
    Marin M, Nguyen HQ, Langidrik JR, Edwards R, Briand K, Papania MJ, Seward JF, LeBaron CW.
    Clin Infect Dis; 2006 Feb 01; 42(3):315-9. PubMed ID: 16392073
    [Abstract] [Full Text] [Related]

  • 14. Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine.
    St Sauver JL, Dhiman N, Ovsyannikova IG, Jacobson RM, Vierkant RA, Pankratz VS, Jacobsen SJ, Poland GA.
    Hum Immunol; 2005 Jul 01; 66(7):788-98. PubMed ID: 16112026
    [Abstract] [Full Text] [Related]

  • 15. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K.
    N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278
    [Abstract] [Full Text] [Related]

  • 16. Confirmed interruption of indigenous measles transmission in Catalonia.
    Salleras L, Domínguez A, Torner N.
    Euro Surveill; 2001 Jul 24; 6(7):113-7. PubMed ID: 12631955
    [Abstract] [Full Text] [Related]

  • 17. Rubella elimination programme strengthened through measles elimination programme in Catalonia.
    Domínguez A, Torner N, Martínez A, Costa J, Plans P, Ciruela P, Salleras L.
    Vaccine; 2006 Feb 27; 24(9):1433-7. PubMed ID: 16226357
    [Abstract] [Full Text] [Related]

  • 18. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V, Giannaki M, Vounatsou M, Bakoula C, Grafakos S.
    Bone Marrow Transplant; 2004 Jun 27; 33(12):1187-90. PubMed ID: 15077129
    [Abstract] [Full Text] [Related]

  • 19. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [Abstract] [Full Text] [Related]

  • 20. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL, Yang YH, Wang LC, Lin YT, Tsai YY, Chiang BL.
    J Microbiol Immunol Infect; 2005 Jun 01; 38(3):169-75. PubMed ID: 15986066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.